s6y
Company name or ticker
Search
CymaBay Therapeutics, Inc.
8-K
Material agreement
Filed
Thursday, January 5, 2017
Period
Dec 30, 2016
Accession number
0001193125-17-002073
Documents
Current report filing
8-K
On sec.gov
Filing index
All files
Complete submission text
SGML header